Diagnosis of Skeletal Metastases and Assessment of Response to Treatment
Author:
- 1 January 1994
- book chapter
- Published by Springer Nature
- No. 312,p. 93-108
Abstract
The skeleton is one of the commonest sites of metastatic cancer, and skeletal metastases are associated with significant morbidity which may seriously affect the patients quality of life. There are two main reasons for wanting to detect skeletal metastases, (a) The diagnosis of a painful lesion in a patient who may or may not be known to have cancer, and (b) the staging of cancer. The latter includes both the assessment of the extent of dissemination in a patient with metastatic cancer and the assessment of a patient with apparently “early” cancer in an attempt to stage the disease before starting treatment. However, once a skeletal metastasis has been diagnosed, it is not sufficient to know only about the presence of the metastasis. There are several other questions that must be answered before the patient can be adequately treated. These include: (a) the exact site of the lesion(s); (b) the degree and site of dissemination; (c) the presence of any complications — hypercalcaemia, impending fracture, pathological fracture, spinal instability or neural compression; (d) soft-tissue involvement; and (e) the vascularity of the lesion.Keywords
This publication has 47 references indexed in Scilit:
- A Caution about the Use of MRI to Diagnose Spinal Cord CompressionNew England Journal of Medicine, 1990
- CA15-3: Its relationship to clinical stage and progression to metastatic disease in breast cancerBritish Journal of Surgery, 1989
- Phase II study of low dose aminoglutethimide 250 mg/day plus hydrocortisone in advanced postmenopausal breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breastEuropean Journal of Cancer and Clinical Oncology, 1988
- Osteocalcin: a potential marker of metastatic bone disease and response to treatmentEuropean Journal of Cancer and Clinical Oncology, 1988
- Skeletal MetastasesClinical Orthopaedics and Related Research, 1986
- Calcium Excretion in Metastatic Prostatic CarcinomaBritish Journal of Urology, 1984
- THE ASSESSMENT OF RESPONSE TO THERAPY OF BONE METASTASES IN BREAST CANCERAustralian and New Zealand Journal of Medicine, 1984
- The significance of occult skeletal metastases, detected by skeletal scintigraphy, in patients with otherwise apparently “early” mammary carcinomaBritish Journal of Surgery, 1975
- Letter: Predictive value of hydroxyproline: creatinine ratio in advanced breast cancer.BMJ, 1975